tDCS Combined With Therapeutic Exercise in Fibromyalgia Patients
Effects of Transcranial Direct Current Stimulation Combined With Therapeutic Exercise in Fibromyalgia Patients. A Triple-blinded, Randomized, Placebo-controlled Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
The purpose of this study is to assess the effects on pain of transcranial direct current stimulation combined with therapeutic exercise in fibromyalgia patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2019
CompletedFirst Posted
Study publicly available on registry
August 8, 2019
CompletedStudy Start
First participant enrolled
September 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2020
CompletedJune 11, 2021
June 1, 2021
7 months
June 14, 2019
June 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in referred pain area after suprathreshold pressure stimulation from baseline to post-treatment
A pressure algometer (Force Ten™, Wagner Instruments, USA) will be used. It will be performed on the infraspinatus muscle (point equidistant between the midpoint of the spine of the scapula, the inferior angle of the scapula and the midpoint of the medial border of the scapula) at a constant suprathreshold pressure (20% above the pressure pain threshold) for 60 seconds. After the stimulation, the subject should draw the induced pain area on a digital bodychart using the Navigate Pain application (Navigate Pain, Aalborg University, Denmark).
Baseline; immediately after intervention; 1-month after intervention
Change in pain intensity from baseline to post-treatment
It will be measured with a visual analog scale (VAS) of 100 millimeters in length. The subject has to indicate the level of pain he feels, being 0 the absence of pain and 100 the maximum imaginable
Baseline; immediately after intervention; 1-month after intervention
Secondary Outcomes (4)
Fibromyalgia Impact Quality-of-Life
Baseline; immediately after intervention; 1-month after intervention
Anxiety
Baseline; immediately after intervention; 1-month after intervention
Pain catastrophizing
Baseline; immediately after intervention; 1-month after intervention
Depression
Baseline; immediately after intervention; 1-month after intervention
Other Outcomes (1)
Blinding
Immediately after intervention
Study Arms (3)
Real tDCS + exercise
EXPERIMENTALTranscranial direct current stimulation combined with therapeutic exercise
Sham tDCS + exercise
SHAM COMPARATORSham transcranial direct current stimulation combined with therapeutic exercise
Control
NO INTERVENTIONNo treatment.
Interventions
Real tDCS (STARTSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for five sessions on alternate days.tDCS is a galvanic current applied by a cap for 20 minutes at an intensity of 2 milliamps.
Sham current (STARSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for five sessions on alternate days. Sham tDCS will be applied for the same time than real tDCS.
The therapeutic exercise program will include aerobic exercise and muscle strengthening for five sessions on alternate days. The program will include exercises and will last 30-45 minutes.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years.
- Fulfilled the 2010 American Colleague of Rheumatology criteria for fibromyalgia.
- Normal pain intensity of 4 or more points on a visual analog scale.
- Able to participated in a therapeutic exercise program.
- Understanding of spoken and written Spanish.
You may not qualify if:
- Pregnancy or breastfeeding.
- Metallic implants in the head.
- Tumor, trauma or surgery in the brain.
- Epilepsy or stroke.
- History of substance abuse in the last 6 months.
- Use of carbamazepine in the last 6 months.
- Severe depression (Beck Depression Index II of 29 or more).
- Diagnosed psychiatric pathology.
- Rheumatic pathology not medically controlled.
- Coexisting autoimmune pathology.
- Chronic inflammatory disease (rheumatoid arthritis, erythematosus systemic lupus, inflammatory bowel disease).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital General Nuestra Señora del Prado
Talavera de la Reina, Toledo, 45600, Spain
Related Publications (1)
Arroyo-Fernandez R, Avendano-Coy J, Velasco-Velasco R, Palomo-Carrion R, Bravo-Esteban E, Ferri-Morales A. Effectiveness of Transcranial Direct Current Stimulation Combined With Exercising in People With Fibromyalgia: A Randomized Sham-Controlled Clinical Trial. Arch Phys Med Rehabil. 2022 Aug;103(8):1524-1532. doi: 10.1016/j.apmr.2022.02.020. Epub 2022 Mar 22.
PMID: 35331718DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2019
First Posted
August 8, 2019
Study Start
September 2, 2019
Primary Completion
March 27, 2020
Study Completion
March 27, 2020
Last Updated
June 11, 2021
Record last verified: 2021-06